Midgard Science

Labs / ADME, DMPK & toxicology

Nona Biosciences

Cambridge, MA, United States · nonabio.com

Nona Biosciences is a global biotechnology company that provides integrated antibody and siRNA discovery through IND filing. It serves drug discovery and development partners with technologies and services spanning target validation, discovery, screening, engineering, toxicology, and IND-enabling CMC.

They take quote requests by email.

What they offer

  • Fully Human Antibody Discovery

    Supports discovery of fully human antibodies from target validation through lead generation.

  • siRNA Discovery

    Provides discovery workflows for siRNA therapeutics.

  • Antibody Screening Capabilities

    Offers screening strategies including single B cell, CAR-based, display, and hybridoma screening.

  • Beacon Single B Cell Screening

    Uses Beacon-based single B cell screening to identify antibody binders and candidates.

  • CAR-based Functional Screening

    Performs functional screening using CAR-based approaches.

  • Display Screening

    Screens antibody candidates using display-based methods.

  • Hybridoma Screening

    Screens hybridoma-derived antibodies for candidate selection.

  • Antibody Engineering Capability

    Provides antibody engineering to optimize lead molecules.

  • Bispecific/Multispecific Antibody Engineering

    Designs and engineers bispecific and multispecific antibody formats.

  • Bispecific Antibody Developability Assessment

    Assesses bispecific antibodies for developability properties.

  • ADC Engineering & Conjugation

    Supports antibody-drug conjugate engineering and conjugation work.

  • Toxicology and Safety Assessment

    Provides toxicology and safety assessment services.

  • IND-enabling CMC

    Supports IND-enabling chemistry, manufacturing, and controls activities.

  • Targeted Cargo Delivery Systems

    Develops targeted delivery systems for cargo modalities.

  • mRNA-LNP Delivery

    Develops mRNA delivery using lipid nanoparticles.

  • Blood Brain Barrier Delivery

    Works on delivery systems for crossing the blood-brain barrier.

  • In Vivo CAR Delivery

    Develops in vivo CAR delivery approaches.

  • Oligonucleotide Delivery

    Develops delivery systems for oligonucleotides.

  • Integrated Idea – IND Program

    Provides an integrated path from ideation to IND filing.

What they work on

Modalities
Antibody, Bispecific, ADC, Oligonucleotide, mRNA, Cell therapy, LNP / formulation
Species and models
Harbour Mice® HCAb, Harbour Mice® H2L2, mice, Beacon, hybridoma
Assays and studies
single B cell screening, B cell sorting, functional screening, display screening, hybridoma screening, developability assessment, affinity prioritization
Instruments and platforms
Beacon
Scale and capacity
140+ partners, 380+ projects, 20+ IND/Clinical Stage
Type
CRDMO
Serves
global
Address
2026 Nona Biosciences Appoints Dr. Peng Wang as Chief Operating Officer to Advance Platform Capabilitie

Similar labs. Aurigene Pharmaceutical Services, Transcenta Holding, Sparx BIO, Evotec

Found in a contract services directory. Listing built from nonabio.com. Work here? Claim this listing.

Nona Biosciences · Midgard Science